The lncRNA MALAT1 was shown to contribute to tumor progression in ER‐positive (also known as luminal) cell lines and has been shown to control the expression of CD133 in the dedifferentiation process of breast cancer cells (Jadaliha et al, 2016; Zhang et al, 2012). This evidence concerns the gene MALAT1 and breast carcinoma.